Redirecting to https://www.astrazeneca-us.com/content/az-us/media/press-releases/2020/tagrisso-approved-in-the-us-for-the-adjuvant-treatment-of-patients-with-early-stage-egfr-mutated-lung-cancer-12212020.html...

Click here if your browser doesn't automatically take you to this page.